JP2000517295A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000517295A5 JP2000517295A5 JP1998507631A JP50763198A JP2000517295A5 JP 2000517295 A5 JP2000517295 A5 JP 2000517295A5 JP 1998507631 A JP1998507631 A JP 1998507631A JP 50763198 A JP50763198 A JP 50763198A JP 2000517295 A5 JP2000517295 A5 JP 2000517295A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9616351.4A GB9616351D0 (en) | 1996-08-02 | 1996-08-02 | Vaccine composition |
| GB9616351.4 | 1996-08-02 | ||
| PCT/EP1997/004326 WO1998005355A1 (en) | 1996-08-02 | 1997-07-31 | Vaccine composition against malaria |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000517295A JP2000517295A (ja) | 2000-12-26 |
| JP2000517295A5 true JP2000517295A5 (https=) | 2005-04-07 |
Family
ID=10797980
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10507631A Pending JP2000517295A (ja) | 1996-08-02 | 1997-07-31 | マラリア用ワクチン組成物 |
Country Status (32)
| Country | Link |
|---|---|
| US (2) | US20020172692A1 (https=) |
| EP (2) | EP0957933B1 (https=) |
| JP (1) | JP2000517295A (https=) |
| KR (1) | KR20000029747A (https=) |
| CN (1) | CN1241639C (https=) |
| AP (1) | AP1166A (https=) |
| AR (1) | AR008799A1 (https=) |
| AT (1) | ATE394119T1 (https=) |
| AU (1) | AU706303B2 (https=) |
| BG (1) | BG63290B1 (https=) |
| BR (1) | BR9710913A (https=) |
| CA (1) | CA2262402A1 (https=) |
| CO (1) | CO4650186A1 (https=) |
| CZ (1) | CZ290826B6 (https=) |
| DE (1) | DE69738672D1 (https=) |
| DZ (1) | DZ2283A1 (https=) |
| EA (1) | EA002167B1 (https=) |
| GB (1) | GB9616351D0 (https=) |
| ID (1) | ID17860A (https=) |
| IL (1) | IL128318A (https=) |
| MA (1) | MA24291A1 (https=) |
| MY (1) | MY116128A (https=) |
| NO (1) | NO319844B1 (https=) |
| OA (1) | OA10969A (https=) |
| PE (1) | PE97298A1 (https=) |
| PL (1) | PL188741B1 (https=) |
| SK (1) | SK282438B6 (https=) |
| TR (1) | TR199900195T2 (https=) |
| UA (1) | UA68336C2 (https=) |
| UY (1) | UY24654A1 (https=) |
| WO (1) | WO1998005355A1 (https=) |
| ZA (1) | ZA976815B (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9915204D0 (en) * | 1999-06-29 | 1999-09-01 | Smithkline Beecham Biolog | Vaccine |
| AU2003285932A1 (en) | 2002-10-23 | 2004-05-13 | Glaxosmithkline Biologicals S.A. | Methods for vaccinating against malaria |
| NZ548166A (en) * | 2003-12-01 | 2010-06-25 | Meiji Dairies Corp | Peptide inhibiting angiontensin converting enzyme |
| GB0513421D0 (en) * | 2005-06-30 | 2005-08-03 | Glaxosmithkline Biolog Sa | Vaccines |
| DK1909830T3 (da) * | 2005-08-02 | 2011-12-19 | Novartis Vaccines & Diagnostic | Formindskelse af interferens mellem olieholdige adjuvanser og antigener indeholdende overfladeaktivt middel |
| GB0614254D0 (en) * | 2006-07-18 | 2006-08-30 | Smithkline Beecham Biolog | Vaccine |
| US9364525B2 (en) * | 2006-07-18 | 2016-06-14 | Glaxosmithkline Biologicals Sa | Vaccines for malaria |
| JP5814507B2 (ja) | 2006-09-07 | 2015-11-17 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン |
| KR20100068390A (ko) | 2007-08-13 | 2010-06-23 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 백신 |
| AU2008339980A1 (en) * | 2007-12-21 | 2009-07-02 | Glaxosmithkline Biologicals S.A. | Vaccines for malaria |
| WO2009080803A1 (en) | 2007-12-24 | 2009-07-02 | Glaxosmithkline Biologicals S.A. | Vaccines for malaria |
| US20120015000A1 (en) * | 2008-06-30 | 2012-01-19 | David Lanar | Malaria vaccine of self-assembling polypeptide nanoparticles |
| CA3002946C (en) * | 2009-11-05 | 2021-11-02 | The United States Of America As Represented By The Secretary Of The Navy | Plasmodium falciparum sporozoite and liver stage antigens |
| BR112013004582A2 (pt) | 2010-09-27 | 2016-09-06 | Crucell Holland Bv | método para induzir uma resposta imune em um sujeito contra um antígeno de um parasita que causa a malária |
| GB201116248D0 (en) | 2011-09-20 | 2011-11-02 | Glaxosmithkline Biolog Sa | Liposome production using isopropanol |
| US20130122038A1 (en) | 2011-11-14 | 2013-05-16 | The United States Of America As Represented By The Secretary Of The Department | Heterologous prime-boost immunization using measles virus-based vaccines |
| US9169304B2 (en) | 2012-05-01 | 2015-10-27 | Pfenex Inc. | Process for purifying recombinant Plasmodium falciparum circumsporozoite protein |
| CN104338129B (zh) * | 2013-07-26 | 2017-05-24 | 中国科学院上海巴斯德研究所 | 雷帕霉素作为疫苗佐剂的用途及制备方法 |
| US10695424B2 (en) | 2016-12-07 | 2020-06-30 | Glaxosmithkline Biologicals S.A. | Method of making a liposome composition |
| GB201621686D0 (en) | 2016-12-20 | 2017-02-01 | Glaxosmithkline Biologicals Sa | Novel methods for inducing an immune response |
| GB2600653B (en) | 2017-05-30 | 2022-11-02 | Glaxosmithkline Biologicals Sa | Novel methods |
| BR112020010790A2 (pt) | 2017-12-01 | 2020-11-10 | Glaxosmithkline Biologicals S.A. | purificação da saponina |
| WO2020245207A1 (en) | 2019-06-05 | 2020-12-10 | Glaxosmithkline Biologicals Sa | Saponin purification |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3280028D1 (en) * | 1981-05-21 | 1989-12-28 | Wellcome Found | Protozoal antigen |
| ES8800273A1 (es) * | 1985-03-28 | 1987-11-01 | Univ New York | Perfeccionamientos en la fabricacion de conjugados de proteinas portadores de antigenos inmunogenicos para vacunas contra la malaria |
| GB8819209D0 (en) * | 1988-08-12 | 1988-09-14 | Research Corp Ltd | Polypeptide & dna encoding same |
| GB9012580D0 (en) * | 1990-06-06 | 1990-07-25 | Univ Nijmegen | Novel protein |
| FR2679776A1 (fr) * | 1991-07-31 | 1993-02-05 | Pasteur Institut | Melange de constituants peptidiques ayant des proprietes vaccinantes contre le paludisme, notamment du a plasmodium falciparum. |
| AU2927892A (en) * | 1991-11-16 | 1993-06-15 | Smithkline Beecham Biologicals (Sa) | Hybrid protein between cs from plasmodium and hbsag |
| US6169171B1 (en) * | 1992-02-27 | 2001-01-02 | Smithkline Beecham Biologicals (S.A.) | Hybrid protein between CS from plasmodium and HBSAG |
| CA2138997C (en) * | 1992-06-25 | 2003-06-03 | Jean-Paul Prieels | Vaccine composition containing adjuvants |
| GB9326253D0 (en) * | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| AUPM368994A0 (en) * | 1994-02-04 | 1994-02-24 | Saramane Pty Ltd | Malaria merozoite antigen subunit vaccine |
| FR2744724B1 (fr) * | 1996-02-14 | 2002-08-02 | Pasteur Institut | Proteine recombinante contenant un fragment c-terminal de la proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques |
| FR2744723A1 (fr) * | 1996-02-14 | 1997-08-14 | Pasteur Institut | Proteine recombinante contenant un fragment c-terminal d'une proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques |
-
1996
- 1996-08-02 GB GBGB9616351.4A patent/GB9616351D0/en active Pending
-
1997
- 1997-07-30 DZ DZ970133A patent/DZ2283A1/fr active
- 1997-07-31 AU AU42040/97A patent/AU706303B2/en not_active Ceased
- 1997-07-31 ID IDP972672A patent/ID17860A/id unknown
- 1997-07-31 MA MA24749A patent/MA24291A1/fr unknown
- 1997-07-31 TR TR1999/00195T patent/TR199900195T2/xx unknown
- 1997-07-31 WO PCT/EP1997/004326 patent/WO1998005355A1/en not_active Ceased
- 1997-07-31 AP APAP/P/1999/001448A patent/AP1166A/en active
- 1997-07-31 UA UA99010527A patent/UA68336C2/uk unknown
- 1997-07-31 SK SK115-99A patent/SK282438B6/sk unknown
- 1997-07-31 CA CA002262402A patent/CA2262402A1/en not_active Abandoned
- 1997-07-31 PL PL97331424A patent/PL188741B1/pl not_active IP Right Cessation
- 1997-07-31 ZA ZA9706815A patent/ZA976815B/xx unknown
- 1997-07-31 CN CNB971983607A patent/CN1241639C/zh not_active Expired - Fee Related
- 1997-07-31 JP JP10507631A patent/JP2000517295A/ja active Pending
- 1997-07-31 EP EP97940062A patent/EP0957933B1/en not_active Expired - Lifetime
- 1997-07-31 MY MYPI97003495A patent/MY116128A/en unknown
- 1997-07-31 BR BR9710913A patent/BR9710913A/pt not_active Application Discontinuation
- 1997-07-31 EA EA199900069A patent/EA002167B1/ru not_active IP Right Cessation
- 1997-07-31 KR KR1019997000855A patent/KR20000029747A/ko not_active Ceased
- 1997-07-31 EP EP05077131A patent/EP1623720A3/en not_active Withdrawn
- 1997-07-31 CZ CZ1999292A patent/CZ290826B6/cs not_active IP Right Cessation
- 1997-07-31 AT AT97940062T patent/ATE394119T1/de not_active IP Right Cessation
- 1997-07-31 DE DE69738672T patent/DE69738672D1/de not_active Expired - Fee Related
- 1997-07-31 IL IL12831897A patent/IL128318A/en not_active IP Right Cessation
- 1997-08-01 PE PE1997000672A patent/PE97298A1/es not_active Application Discontinuation
- 1997-08-01 UY UY24654A patent/UY24654A1/es not_active IP Right Cessation
- 1997-08-01 AR ARP970103502A patent/AR008799A1/es not_active Application Discontinuation
- 1997-08-01 CO CO97044242A patent/CO4650186A1/es unknown
-
1999
- 1999-02-01 NO NO19990464A patent/NO319844B1/no unknown
- 1999-02-02 OA OA9900022A patent/OA10969A/en unknown
- 1999-02-02 BG BG103141A patent/BG63290B1/bg unknown
-
2001
- 2001-12-18 US US10/024,860 patent/US20020172692A1/en not_active Abandoned
-
2006
- 2006-08-11 US US11/463,933 patent/US20060292170A1/en not_active Abandoned